---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058532"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:13:22.991478+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Palvella shareholders elect Heron, Wessel as Class II directors; ratify EY

## Summary
- Elaine J. Heron elected with 6,647,082 votes for, 1,255 withheld; Tadd S. Wessel with 6,487,034 for, 161,303 withheld.
- Ratification of Ernst & Young as independent auditor for 2025: 7,299,907 for, 8,352 against, 7,334 abstain.
- Advisory approval of 2024 named executive officer compensation: 6,550,393 for, 61,078 against, 36,866 abstain.
- Broker non-votes on proposals 1 and 3 were 667,256.

## SEC filing metadata
- accession: 0001104659-25-058532
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/0001104659-25-058532-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/tm2517565d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058532
- JSON: https://secwatch.observer/filing/0001104659-25-058532.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058532.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.